PhageBiotix™ UTS, a revolutionary new proprietary formula containing lytic bacteriophages, is intended for use as a dietary ingredient to help maintain healthy gut and urinary tract microflora and to increase resilience against Escherichia coli (UPEC) – the bacterium associated with an unhealthy urinary tract. The product contains naturally occurring lytic bacteriophages with strong natural abilities to encourage beneficial microbiome communities. Bacteriophages have been used for over 100 years as natural microorganisms for supporting a healthy, balanced microbiome ^1,2,3.

PhageBiotix™ UTS is manufactured in SQF-certified cGMP (21 CFR 117 compliant) facility in the United States.

PhageBiotix™ UTS is the choice to help maintain healthy gut microflora because it:

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References:

1. Galtier, M., De Sordi, L., Maura, D., Arachchi, H., Volant, S., Dillies, M.A., Debarbieux, L., Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition. Environmental Microbiology, 2016, 18: 2237-2245

2. Leitner, L., et al., Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebocontrolled, double-blind clinical trial. The Lancet Infectious Diseases, 2021, 21:427-436

3. Sulakvelidze, A.; Kutter, E., Bacteriophage therapy in humans. In Bacteriophages: Biology and Application, Kutter, E.; Sulakvelidze, A., Eds. CRC Press: Boca Raton, FL, 2005; pp 381-436.